We still don’t know if the 6 CVST clots out of 6.8 million J&J vaccinations in the US are really related. One thing we are more certain? FDA says “no cases of CVST with thrombocytopenia with the Pfizer/BioNTech and Moderna vaccines”. #COVID19#CovidVaccine boston.com/news/coronavir…
3) Also why did they pause? Here is the rationale. Digest it from the “shark gate” lens if it was found out later and we didn’t do anything before when it was suspicious.
3) The new theory is that Michigan surge is due to Ontario. “Where do we have big surges? We have big surges in Michigan & in Minnesota, and also kind of around Buffalo, New York State. Alright, so what (do) those 3 have in common? They all touch Ontario” nationalpost.com/news/world/mic…
Higher blood clot risk due to COVID—People who have recovered from #COVID19, regardless of the severity of their disease, may be at risk of developing blood clots due to an overactive immune system. Thread 🧵 straitstimes.com/singapore/heal…
2) “Blood samples from 30 patients who had recovered from mild, moderate and severe Covid-19 were collected a month after they had been discharged from the hospital.
3) “All of them were found to have blood vessel damage, possibly arising from a lingering immune response, which could trigger the formation of blood clots.
Around half of the patients had pre-existing cardiovascular risks, such as diabetes and hypertension.
Brazilian 🇧🇷 children—even babies—are dying of #COVID19. Comparing excess of deaths by unspecified ARS during pandemic, & found 10x more deaths than past years—estimates that #SARSCoV2 in fact killed 2,060 🇧🇷 children <9 years old, including 1,302 babies. bbc.com/news/world-lat…
2) Many kids develop a “condition called multi-system inflammatory syndrome (MIS).
This is an extreme immune response to the virus, which can cause inflammation of vital organs.
3) Experts say the syndrome, which affects children up to six weeks after they are infected with coronavirus, is rare, but leading epidemiologist Dr Fatima Marinho from the University of São Paolo, says that, during the pandemic, she is seeing more cases of MIS than ever before
💡GOOD NEWS—Moderna expects to have a #COVID19 vaccine booster shot available by the fall adapted for likely the #B1351 🇿🇦 variant. For the past month, NIH has been testing 3rd vaccine doses to enhance Moderna’s efficacy against emerging variants. 🧵 cnbc.com/2021/04/14/cov…
2) Experts hope the new booster shots will help protect against B.1.351, which has been shown to reduce the efficacy of vaccines. Moderna anticipates that annual COVID booster shots will become commonplace, and develop a combination flu and COVID vaccine in the future.
3) The Massachusetts-based biotech firm expects to submit booster shot data to U.S. regulators within a few months, Bancel told CNBC on Wednesday
INTUBATION WITHOUT SEDATIVES—Hospitals in Rio has run out of intubation sedatives. Patients now get intubated with diluted or no sedatives at all—being mechanically tied to their beds wide awake as they get tubed. ICU doctors admit it is form of “torture”. g1.globo.com/rj/rio-de-jane…
2) TRANSLATED: A nurse at the Albert Schweitzer Municipal Hospital in Realengo, in Rio's West Zone, says that patients with the most severe form of the disease are intubated, wokenand tied to beds due to the absence of medications.
3) Without the medication, the teams unfold looking for alternatives.
According to intensivist physicians, mechanical restraint can be used, but the patient needs to be medicated with at least a mild sedation.
MIXING SUBSTITUTE VACCINE—Germany 🇩🇪 has just approved a new move to give people aged <60 who have been given a first dose of the Oxford-AstraZeneca #COVID19 vaccine a different jab for their 2nd dose— approving Pfizer & Moderna for 2nd dose as substitute. france24.com/en/europe/2021…
2) Germany announced on March 30 that it would no longer offer the two-dose AstraZeneca vaccine to people aged under 60 due to concerns over a possible link to rare cases of blood clots.
3) DPA news agency said ministers agreed at a meeting that people in the younger age group who received a first AstraZeneca dose before the March 30 announcement will be offered either the BioNTech-Pfizer jab for their second dose, or the Moderna vaccine.